Dr. Reilkoff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
909 Fulton St SE
Minneapolis, MN 55455Phone+1 612-672-7422
Summary
- Dr. Ronald Reilkoff is a pulmonologist and critical care specialist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including University of Minnesota Medical Center, Fairview and Fairview Southdale Hospital. He received his medical degree from University of North Dakota School of Medicine and Health Sciences and has been in practice 12 years. He specializes in critical care medicine and is experienced in alpha-1 antitrypsin deficiency, chronic obstructive pulmonary disease, critical care medicine, and general pulmonology.
Education & Training
- Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2005 - 2008
- University of North Dakota School of Medicine and Health SciencesClass of 2005
- Yale-New Haven Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine
Certifications & Licensure
- MN State Medical License 2011 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Vitamin C and Septic Shock Start of enrollment: 2017 Dec 20
Publications & Presentations
PubMed
- 35 citationsEvaluating Vitamin C in Septic Shock: A Randomized Controlled Trial of Vitamin C Monotherapy.David A Wacker, Susan L Burton, John P Berger, A J Hegg, Jamie Heisdorffer
Critical Care Medicine. 2022-05-01 - 313 citationsFibrocytes: emerging effector cells in chronic inflammationRonald Reilkoff, Richard Bucala, Erica L. Herzog
Nature Reviews. Immunology. 2011-06-01 - 46 citationsA multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19Michael A. Puskarich, Nathan W. Cummins, Nicholas E. Ingraham, David A. Wacker, Ronald Reilkoff
Eclinicalmedicine. 2021-06-17
Press Mentions
- Hospital-Onset Sepsis: Why the Brouhaha?May 30th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: